Back to search
Mild and Moderate Atopic Dermatitis Patients
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Mild and Moderate Atopic Dermatitis Patients trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Mild and Moderate Atopic Dermatitis Patients trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
Elidel® is indicated for the short-term treatment and long-term management of signs and symptoms of atopic dermatitis (AD) in infants (3 to 23 months), children…
This is a randomized, double-blind, placebo-controlled, multi-center, phase 2 study in patients with mild to moderate Atopic Dermatitis(AD), which consists of 2…